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Abstract Glial fibrillary acidic protein (GFAP) is the
characteristic intermediate filament (IF) protein in astro-
cytes. Expression of its main isoforms, GFAPa and GFAPd,
varies in astrocytes and astrocytoma implying a potential
regulatory role in astrocyte physiology and pathology. An
IF-network is a dynamic structure and has been functionally
linked to cell motility, proliferation, and morphology. There
is a constant exchange of IF-proteins with the network. To
study differences in the dynamic properties of GFAPa and
GFAPd, we performed fluorescence recovery after photo-
bleaching experiments on astrocytoma cells with
fluorescently tagged GFAPs. Here, we show for the first
time that the exchange of GFP–GFAPd was significantly
slower than the exchange of GFP–GFAPa with the IF-
network. Furthermore, a collapsed IF-network, induced by
GFAPd expression, led to a further decrease in fluorescence
recovery of both GFP–GFAPa and GFP–GFAPd. This
altered IF-network also changed cell morphology and the
focal adhesion size, but did not alter cell migration or pro-
liferation. Our study provides further insight into the
modulation of the dynamic properties and functional con-
sequences of the IF-network composition.
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Introduction
Intermediate filaments (IFs) are part of the cytoskeleton.
Together with actin filaments and microtubules, they form
an integrated system that regulates many cellular processes,
such as cell morphology, cell signaling, cell migration, and
proliferation [1–4]. The main IF protein expressed in
astrocytes is glial fibrillary acidic protein (GFAP). The ten
different GFAP isoforms, of which GFAPa is the canonical
isoform, are formed by alternative splicing [5, 6]. The
function of GFAP and its isoforms is still elusive, but there
is emerging evidence that at least one isoform, GFAPd,
alters the properties of the IF network. GFAPd differs from
GFAPa only in its C-terminal tail, and in non-pathological
human brains, and is expressed in specific types of astro-
cytes, including the adult neural stem cells in the human
subventricular zone and subpial astrocytes [7–9]. The
GFAPd protein has a unique 41 amino acids long C-ter-
minal tail [6, 7] and is one amino acid shorter than the
canonical GFAPa protein [10]. In pathological conditions,
GFAPd is expressed in certain types of reactive gliosis and
glial tumors [11–15]. The tail of GFAPd disables the
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protein to form homodimers making it impossible to self-
assemble [16]. GFAPd is able to form heterodimers with
other type III IF proteins and can, therefore, be integrated
in an IF network. Depending on the level of expression and
the concentration of other IFs present, GFAPd is either
tolerated in the network or it causes the whole IF network
to collapse in the perinuclear region [7, 17]. Assembly
experiments in a cell free environment showed that GFAP
networks start to collapse when there is more than 10 % of
GFAPd protein present in the network [17].
In the cell, IF proteins are present in a soluble form in
the cytoplasm and in filamentous structures that form an
important part of the cell’s cytoskeleton [18, 19]. These IF
networks are highly motile structures that are constantly
rearranged. The proteins within the filaments are also
dynamic, since there is an active exchange between the
filamentous and non-filamentous pool of IF proteins [20–
23]. IF networks that are already formed can be actively
disassembled by phosphorylation of IF proteins, whereas
the lack of dephosphorylation will hamper new IF network
assembly [24, 25]. It has been shown that phosphorylation
of GFAP at the N-terminal head domain by kinases, such as
Aurora B or CF kinase, is important for proper dissociation
from the filaments during cytokinesis [25–28].
Previously, we showed both in vitro and in vivo that
physiological levels of GFAPd are well tolerated in a GFAPa
network [7, 8, 15, 17], although it has also been shown in a
cell free system and in vitro that a high expression of GFAPd
can lead to an IF network collapse [7, 16, 17]. These col-
lapses resemble aggregates of GFAP proteins, which occur
when cells are transfected with mutant R416W GFAP [29].
This is one of the mutations in GFAP that causes Alexander
disease (AxD), a fatal neurodegenerative disease character-
ized by leukodystrophy, macrocephaly, and psychomotor
retardation [30]. A pathological hallmark of this disease is
the presence of Rosenthal fibers, which are astrocytic
aggregates that are comprised of GFAP, ubiquitinated pro-
teins, and stress proteins, such as heat shock proteins like aB-
crystallin (CRYAB) and heat shock protein 27 (HSP27) [29,
31–34], but also IF-associated proteins like plectin [35]. AxD
mutations in GFAP and the subsequent collapse of the net-
work influence astrocyte viability, morphology, and
glutamate transport, and aggregates or accumulations of
mutant AxD GFAP have a profound effect on astrocyte
biology and physiology [36–39].
There is increasing evidence that GFAPd changes IF
properties [17, 40]. Here, we studied in more detail the
differences in dynamic exchange of GFAPa and GFAPd
with the IF network in vitro. Furthermore, we analyzed the
functional consequences of GFAPa or GFAPd expression
by assessing the effect of the altered GFAP network on the
dynamics and localization of other IF proteins in the cells,
on cell morphology, and focal adhesions. We also
determined the effect on cell migration and proliferation,
since it has been reported that GFAP affects these pro-
cesses [4, 41–43]. Investigating the dynamic properties of
the different GFAP isoforms and the effects of the different
GFAP networks on cellular functions will contribute to our
understanding of the consequences of modulation of the
GFAP network for astrocyte physiology and pathology.
Methods
Cell culturing and transfections
U251MG human astrocytoma cells (gift from A.M.W. van
Dam, VU University Medical Center, Department of
Anatomy and Neurosciences, Amsterdam, The Nether-
lands) and U343MG human astrocytoma cells (gift from
Prof Dr. R. Quinlan, Durham University, Durham, UK)
were cultured in DMEM Glutamax (Gibco) mixed 1:1 with
Ham’s F10 medium (Gibco) containing 10 % Fetal bovine
serum (FBS) (Gibco) and 10-U/mL penicillin streptomycin
(P/S) (Invitrogen). Human embryonic kidney (HEK293T)
cells were cultured in DMEM/Glutamax with 10 % FBS,
1 % P/S, and 1 % extra Glutamax (all Invitrogen). All cells
were cultured in uncoated plastic flasks (Corning) at 37 C
in a humidified atmosphere, with 5 % CO2.
Isolation of primary human astrocytes
Primary human adult astrocytes were obtained from freshly
dissected postmortem subcortical white matter of a
79-year-old female control donor (NBB 2010-038), with a
postmortem delay of \18 hours (h) and a cerebrospinal
fluid pH of 6.30. The tissue was obtained from the
Netherlands Brain Bank (NBB), which performs brain
autopsies with short postmortem intervals. The brain
donors gave informed consent for using the tissue and for
accessing the extensive neuropathological and clinical
information for scientific research, which is in compliance
with ethical and legal guidelines [44]. The tissue was
collected in 25-mL cold Hibernate A (Invitrogen), and
mechanically dissociated into small pieces. The tissue was
digested with 0.2 % trypsin (Invitrogen) and 0.1 % DNA-
seI (Invitrogen) at 37 C, while shaking for 30 min (min).
Next, 2-mL FBS was added to the mixture, and subse-
quently, the cells were collected by centrifugation. The
pellet was taken up in DMEM without phenol red con-
taining 10 % FBS, 2.5 % Hepes, and 1 % P/S (all
Invitrogen), and the suspension was filtered through a
60-lm mesh screen. Then, Percoll (Amersham/GE
Healthcare) was added (half of the cell suspension vol-
ume), and this mixture was centrifuged at 3220 relative
centrifugal force (rcf) at 4 C for 30 min to separate cells,
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debris, and myelin. The second layer (glial cell containing
fraction) was collected and washed with complete DMEM
(containing 10 % FBS, 1 % P/S, 2.5 % Hepes, and 1 %
gentamycin, all Invitrogen). After centrifugation, the pellet
was taken up in complete DMEM, and cells were seeded in
a 6-cm uncoated culture dish. Microglia adhered to the
dish, and after 6 h at 37 C/5 % CO2, the medium, con-
taining astrocytes, was taken off, centrifuged, and the
microglia depleted pellet was seeded onto poly-L-lysine-
coated wells [PLL, Sigma-Aldrich, 15 lg/mL in PBS, 1 h
at room temperature (RT)] in DMEM/Ham’s F12 Glu-
taMAX medium containing 5 % FBS, 1 % P/S, and 0.25 %
Fungizone (all Invitrogen).
Plasmid construction, transient transfection,
and virus production
Expression vectors were prepared by cloning human
GFAPa and human GFAPd [7, 17, 29] full length cDNA
sequences into the pIRES2EGFP (Clontech). For the
GFAPd constructs, the eGFP sequence was replaced by
mCherry.
GFP tagged GFAP constructs were created by cloning
human GFAPa and GFAPd cDNA sequences [7] in frame
after the eGFP sequence in peGFP using BAMHI and
HindIII as restriction sites (Clontech) to create N-terminal
eGFP tagged GFAPs. The N-terminal side was chosen for
the eGFP tag, since GFAPa and GFAPd differ in their
C-terminal tail. All plasmids were sequenced.
Cells for fluorescence recovery after photobleaching
(FRAP) experiments were transiently transfected using
polyethylenimine (PEI) (Polysciences) or Lipofectamine
(Invitrogen) according to manufacturer’s descriptions.
2.5 lg of plasmid DNA was used for PEI and 1.6 lg for
Lipofectamine [5] in subconfluent 24-wells plates.
Subsequently, to produce lentiviral vectors, the con-
structs were subcloned into a pRRL lenti backbone.
Lentiviruses were produced as described before [45, 46]
with some alterations. In short, 10 9 106 HEK 293T cells
were plated in a 15-cm culture dish and transfected with a
total of 90 lg of the envelope (pMD2.G), packaging
(pCMV-dR8.74) and p156RRL plasmid, containing dif-
ferent expression cassettes per dish, using PEI. In total,
90 lg of DNA was mixed with PEI (67.5 ng/lL), incu-
bated for 15 min at RT, and added dropwise to the cell
culture. The culture medium was replaced 16 h after
transfection, and the medium containing viral particles was
collected 24 h after transfection. Supernatants were ultra-
centrifuged at 22,000 rpm (rotor SW28, Beckman-Coulter)
for 2.5 h. The resulting pellet was resuspended in phos-
phate-buffered saline (PBS) (pH 7.4), aliquoted and stored
at -80 C until further use.
To measure viral titers, a dilution series across five
orders of magnitude of the viral stock solutions was made
and HEK293T cells were transduced. After 2 days of
incubation at 37 C, the number of transduced fluorescent
cells at the different viral dilutions was counted, and the
viral titer was determined in transducing units (TU)/mL.
Creating stable cell lines
For functional experiments, cell lines expressing GFAP
isforms were created. U251 cells were transduced with
lentiviral constructs with a multiplicity of infection of 10.
Medium was refreshed after 16 h. To maintain a population
of transduced cells, cells were sorted on their EGFP or
mCherry expression using fluorescent activated cell sorting
(FACS ARIA II, BD Bioscience, Franklin Lakes, NJ,
USA). In between experiments, U251 cells were stained for
GFAP to ensure that more than 70 % of the cells were
expressing the construct. The primary human astrocytes
were checked for fluorescent reporter expression before
any analysis to ensure cells were expressing GFAP
isoforms.
MTT assay
To measure cell proliferation, an MTT(3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
assay was performed. MTT is reduced into a soluble blue
formazan product by mitochondrial enzymes in living cells
only. Therefore, the amount of formed formazan is pro-
portional to the amount of living cells present [47]. MTT
assays were performed by plating cells in non-coated
plastic 24-wells plates (Greiner). To quantify cells, med-
ium was replaced by 500-lL serum free medium
containing 0.5-mg/mL MTT, which was incubated at 37 C
for 2 h. Cells were subsequently lysed in 100 % DMSO,
which dissolves the purple formazan resulting in a color
change of the DMSO. The amount of purple formazan, and
therefore the amount of cells able to metabolize the MTT,
was measured using a Varioskan Flash (Thermo scientific,
USA), measuring the absorbance at 570 nm. Significance
was tested with a Kruskal–Wallis test with Dunn’s Multiple
Comparison post hoc test on 3 independent experiments.
Every measurement in the independent experiments was
the average of a biological duplicate.
Phospho-histone H3 quantification
To determine the number of actively proliferating cells,
U251 cells expressing GFAP isoforms were plated on non-
coated coverslips and fluorescently stained for phospho-
histone H3 (PHH3) together with the nuclear dye Hoechst
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(1:1000 dilution) (Invitrogen). Subsequently, micrographs
were taken, the number of PHH3 positive, dividing, nuclei
was counted using ImagePro software (version 6.3), and
the percentage of dividing cells was calculated by dividing
the number of PHH3 positive cells by total number of
Hoechst positive nuclei. Per experiment, 5 fields of view
were analyzed and averaged, each containing at least 50
cells. Data from separate experiments were corrected for
inter-experimental variation as stated below. Significance
was tested with a Kruskal–Wallis test with Dunn’s post hoc
test on data from 3 independent experiments.
Migration assay
To measure cell migration, a scratch assay was performed.
U251 cells were plated in a 24-wells plate (100,000 cells
per well) coated with 20-lg/mL PLL at 37 C for 1 h. The
confluent cell monolayer was scratched with a P10 plastic
pipet tip. Pictures were taken using an Axiovert 135 M
(Zeiss) with a Sony XCD-X700 camera (Sony) at the time
points indicated in the results. To quantify cell migration,
the surface area not covered by cells was determined at
different time points. The migration was calculated as the
percentage of uncovered surface area compared with t = 0.
A mean of 9 pictures was measured per condition, in at
least 3 separate experiments. Significance was tested with a
Kruskal–Wallis test with Dunn’s post hoc test.
Single cell motility assay
Single cell motility assays were performed on a Zeiss
Axiovert 2000 inverted microscope (Zeiss, Jena, Ger-
many). A single cell suspension was plated on PLL-coated
glass dishes with four compartments (CELLview, Greiner
bio-one, Alphen a/d Rijn, The Netherlands) and allowed to
adhere for at least 8 h. Dishes were kept on the microscope
in a pre-heated and humidified incubation chamber (OKO
labs) at 37 C and 5 % CO2. Pictures were taken every
10 min with an Axi Aqua camera (Q imaging). Cell
motility was measured by tracking single cells throughout
all frames of the sequence and measuring the average
velocity in lm per min using the manual tracking plugin
from ImageJ (Rasband, W.S., ImageJ, U. S. National
Institutes of Health, Bethesda, Maryland, USA, http://
imagej.nih.gov/ij/, 1997–2012 version 1.46f). Per experi-
ment, at least 20 cells were analyzed per condition in at
least 3 independent experiments. Data from separate
experiments were corrected for inter-experimental varia-
tion as stated in the ‘‘Statistics and factor correction’’
section below. A Kruskal–Wallis test with Dunn’s post hoc
test was performed to test for significance. For the primary
human astrocytes, which were not sorted, we checked for
GFP and mCherry expression to make sure that we only
tracked transduced cells.
Quantitative reverse transcriptase PCR (qPCR)
analysis
U251 cells were transduced like described before. Medium
was refreshed after 16 h. RNA was extracted 7 days after
transduction. RNA was extracted from cells using TRIsure
(Bioline, London, UK) and precipitated in isopropanol
overnight (O/N). Five hundred nanograms of RNA was
reverse transcribed into cDNA with a QuantiTect reverse
transcription kit (Qiagen), as described before [5]. cDNA
was diluted 1:20 before being used as a template in qPCR
assays (SYBR Green PCR Master Mix, Applied Biosys-
tems). qPCR conditions were similar as described before
[5] and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and hypoxanthine phosphoribosyltransferase
(HPRT) were used as reference genes to normalize gene
expression. Data from 4 separate experiments were factor
corrected as stated in the ‘‘Statistics and factor correction’’
section below and tested for significance using a Kruskal–
Wallis test with Dunn’s post hoc test. Primer pairs used are
listed in Table 1.
Western blots
Cells were washed and collected with a cell scraper into
100 lL of cold lysis buffer consisting of a suspension
buffer (0.1 M NaCl, 0.01 M Tris–Hcl (pH 7.6), 1-mM
Ethylenediaminetetraacetic acid (EDTA) with 1 % Triton-
x100) and protease inhibitors were added (100-lg/mL
phenylmethanesulfonylfluoride (PMSF)(Roche Diagnos-
tics) and 0.5-lg/mL Leupeptin (Roche Diagnostics). Cells
were vortexed and incubated for 5 min on ice. Subse-
quently, samples were spun at 11.7 k rcf for 1 min.
Supernatant was taken off and stored at -20 C until fur-
ther use. Protein concentrations were measured using a
BCA kit (Pierce, Thermo Scientific), according to manu-
facturers descriptions. Proteins were mixed with 2X
loading buffer (2X: 100 mM Tris pH 6.8, 4 % SDS, 20 %
glycerol, 0.2 M dithiothreitol, and bromophenol blue),
heated for 5 min at 95 C, and loaded on a 7.5 % SDS-
PAGE reducing gel. After electrophoresis, proteins were
blotted on Whatman Protran membranes (GE Healthcare)
using a semi-dry Trans-Blot system (Biorad) for 60 min.
Blots were incubated with SuMi (50 mM Tris, 150 mM
NaCl, 0.25 % gelatine and 0.5 % Triton X-100, pH 7.4) for
10 min before they were incubated with primary antibodies
at 4 C overnight. Blots were subsequently washed 3 times
in TBS-T (100 mM Tris–Hcl pH 7.4, 150 mM NaCl with
0.2 % Tween-20), before secondary antibodies [IRdye 800
(1:2000) (LI-COR) and Dyelight Cy5 (1:4000) (Jackson
4104 M. Moeton et al.
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Immune Research), diluted in SuMi were incubated at
room temperature for 1 h. Blots were washed again 3 times
in TBS-T before scanning with an Odyssey scanner (LI-
COR). GAPDH was used as a loading control.
Immunocytochemistry
To perform immunocytochemical staining, cells were cul-
tured on uncoated glass coverslips, fixed with 4 %
Paraformaldehyde (PFA), washed in PBS, and incubated in
SuMi buffer for 10 min. Primary antibodies were diluted in
SuMi and incubated at 4 C on a shaker O/N. Cells were
washed 3 times in PBS and, subsequently, incubated with
secondary antibodies and Hoechst 33258 (1:1000 dilution)
(Invitrogen) diluted in SuMi at RT for 1 h. The antibodies
used are listed in Table 2. All secondary antibodies were
from Jackson Immune Research and diluted 1:1400 in
SuMi. Cells were washed again in PBS, before the cover-
slips with cells were mounted on slides with Mowiol
[0.1 M Tris–HCl pH 8.5, 25 % glycerol, 10 % Mowiol
(Calbiochem, Merck Millipore)]. The actin network was
visualized with acti-stain Phalloidin 670 (Cytoskeleton inc;
1:1000 dilution). All fluorescent images were taken with a
Leica SP5 confocal microscope (Leica) with a 63x
objective.
Cell morphology measurements
Phase contrast pictures were taken from the U251 cells
transduced with GFAP isoforms and mCherry (control) on
a Zeiss Axiovert 2000 with an Exi Aqua camera (Q
Imaging, Surrey, Canada). Cell outlines were manually
drawn using Image J. Area and perimeter were measured in
square units. Form factor was calculated as 4p ðAreaÞðPerimeterÞ2,
where perfectly round cells will have a form factor of 1
[43, 48]. Five independent experiments were performed
with 40 cells analyzed per experiment. Data have been
factor corrected for inter-experimental variation as stated
Table 1 qPCR primer pairs of human GFAP isoforms
Transcript Forward primer Reverse primer
GFAPa endogenous CCCACTCTGCTTTGACTGAGC CCTTCTTCGGCCTTAGAGGG
GFAPd endogenous GTGGTAAAGGTGGTGAGTCCTT AGAGGCTGCTGCTTGCTC
Vimentin CGTACGTCAGCAATATGAAAGTGTG TCAGAGAGGTCAGCAAACTTGGA
Nestin GATCTAAACAGGAAGGAAATCCAGG TCTAGTGTCTCATGGCTCTGGTTTT
GFAPa CTTCTCCAACCTGCAGATTCG CACGGTCTTCACCACGATGTT
GFAPd CCGTGCAGACCTTCTCCAA CGTATTGTGAGGCTTTTGAGATATCT
GFAPj GTCAGTACAGCAGGGCCTCG AGGAGCGCTGCAGTGTCACG
GFAPb CGGGCATCGCCAGTCTAG ATCCTGCTCTGGCTCTGCTC
GFAPc CTCAGAAGAGCCTGGACCCA GGCTTCCAGCCTCAGGTTG
GFAPf GCACTGTGCACGTTCCCTG GGTCCTGCCTCACATCACATC
GFAPDEx6 TGCGCGGCACGGATC CACGGTCTTCACCACGATGTT
GFAPD135 TCTGCGCGGCACGGAGTA GGGAATGGTGATCCGGTTCT
GFAPD164 GAGGCGGCCAGTTATTCCC CACGGTCTTCACCACGATGTT
GFAPDEx7 GCGAGGAGAACCGAAACCAG CTTCACCACGATGTTCCTCTTG
Endogenous GFAPa and GFAPd primers are located in the 30UTR part, which is absent in the plasmid cDNA. The primer sequences used were
published before [15]
GFAP glial fibrillary acidic protein
Table 2 Primary antibodies
Antibody Manufacturer Dilution Cat #
Pan GFAP Dako Dako 1:4000 (1:8000 WB) Z0334
hGFAPd Manufactured in house (10-05-2001 Bleed) 1:1000 (1:1300 WB) –
GFAP c-term Santa Cruz 1:4000 (WB) Sc-6170
Vimentin Chemicon 1:3000 AB5733
GAPDH Abcam 1:4000 (WB) AB14247
GFAP glial fibrillary acidic protein, WB western blot, c-term carboxy terminal, hGFAP human GFAP, GAPDH glyceraldehyde-3-phosphate
dehydrogenase
GFAP isoforms control intermediate filament network dynamics, cell morphology, and focal adhesions 4105
123
below. A Kruskal–Wallis test was performed with Dunn’s
post hoc test to test for significance.
Live cell imaging
U343MG cells were imaged for 48 h using a Leica IR-BE
(Leica Microsystems GmbH) inverted wide field micro-
scope at 37 C in a custom built incubator containing 5 %
CO2. Phase contrast and fluorescence images were
acquired with a 40x objective at 10 and 30 min time
intervals during 48 h. The single images were recon-
structed and rendered into a time-lapse using Huygens
software (Scientific Volume Imaging) and Image Pro Plus
(Mediacybernetics).
Fluorescent recovery after photobleaching (FRAP)
FRAP analysis was performed on transiently transfected
U251MG cells. During imaging the temperature was
maintained at 37 C in a humidified incubator chamber
(OKO labs). Cells were analyzed 24 h after transfection.
To monitor dynamics of GFAP in collapsed networks, we
transfected the cells with GFAPd in combination with
either GFP–GFAPa or GFP–GFAPd. FRAP experiments
were carried out on a SP5 Leica Confocal Microscope
(Leica) with a 63x objective. The pinhole was set on
209.99 lm, and the scanning speed was at 400 Hz with a
resolution of 512 9 512 pixels. Bar-shaped regions of
interest (ROI) of 1.5 lm 9 10 lm were bleached with a
488-nm Argon laser (full laser power) until at least 50 % of
the fluorescence was bleached. Immediately after bleach-
ing, a time-series of capturing 10 frames with a 30 s
interval were made. Then, z-stacks were taken manually
every 5 min up to 30 min after bleaching. To ensure that
the bleached ROI did not drift out of focus, z-stacks were
made throughout the whole cell. Three ROIs were bleached
per cell at different locations within the IF network. FRAP
experiments were performed at different days in at least
three separate experiments. This resulted in the following
amount of ROIs measured: 33 9 GFAPa in a network,
30 9 GFAPd in a network, 8 9 GFAPa in a collapse, and
8 9 GFAPd in a collapse.
FRAP analysis
ROIs were positioned in post bleach pictures manually. Per
time point, the position of the ROI was corrected for cell
movement, and average fluorescence was measured using
Image J. The average fluorescence was plotted in time to
obtain fluorescence recovery curves for every ROI. The
half time was calculated by interpolating the time at 50 %
of the fluorescence of the maximum fluorescence at
30 min. The immobile fraction was calculated by com-
paring the fluorescence in the bleached area after recovery
(F?) with the fluorescence before bleaching (Fi) and just
after bleaching (F0). The immobile percentage is defined as
(1 - (F? - F0)/(Fi - F0)) 9 100. For F?, the average of
the last three time points was used for analysis.
Statistics and factor correction
Data obtained from independent experiments were cor-
rected with a factor correction program (version 10.5 2012)
[49] when stated. Kruskal–Wallis, Kolmogorov–Smirnov,
or Mann–Whitney tests were performed to test for signif-
icance. Differences were considered significant at
p\ 0.05. All statistical tests were performed using
Graphpad Prism 5 (version 5.04) (Graphpad Software Inc.,
La Jolla, CA, USA).
Focal adhesion analysis
To analyze focal adhesions, coverslips were coated with
laminin in 24-wells plates. Cells were plated at 10,000 cells
per well. After attaching for 2 days, cells were fixed with
4 % PFA, stained with rabbit anti-phosphorylated-paxillin
(pY118; Life Technologies), and counterstained with
Hoechst and Phalloidin-488.
Fixed and immunostained samples were imaged on an
inverted microscope (Zeiss Axiovert 200) with a Confocal
Spinning-disk Unit (Yokogawa CSU X-1) and an emCCD
camera (Andor iXon 897). Excitation was accurately con-
trolled by 405 nm (Crystalasers), 514 nm (Cobolt), and
642 nm (Spectra Physics) lasers through an acousto-optic
tunable filter (AA Optoelectronics) coupled into the CSU
with a polarization-maintaining optical fiber. Images were
acquired with Andor IQ 2 software, and further processing
and analysis were performed in specifically designed
software (Matlab, Mathworks).
Focal adhesions were automatically detected from the
642-nm fluorescence images. Focal adhesion size could be
at least 0.4 9 0.4 lm and at most 4 9 4 lm. In an image
of 512 9 512 pixels low pass frequency with a cut-off at 2
pixels filtering removed large features. With a subsequent
threshold of 3 times the standard deviation of the image,
we obtained and characterized the focal adhesions. Focal
adhesion size differences were tested using a 2-tailed
Kolmogorov–Smirnov test. Differences were considered
significant if p\ 0.05. Per condition, a different amount of
cells and focal adhesion were measured, but at least
exceeded 30 different cells and a total of more than 700
focal adhesions.
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Results
GFAPd perturbs the GFAP network in astrocytes
Cellular models for studying GFAP isoform function were
established by expression of GFAP isoforms in U251 cells
and primary human astrocytes. The mRNAs of the different
isoforms were highly expressed in the transduced U251 cell
lines (Sup. Fig. 1a, b) and primary human astrocytes (Sup.
Fig. 1d, e). Western blot analysis showed a clear expres-
sion of either GFAPa or d (Sup. Fig. 1c), while the control
(Ctrl) only showed a band with the pan GFAP antibody,
representing endogenous GFAPa. The endogenous
expression of the other GFAP isoforms was determined
with qPCR and is presented as a percentage of the
canonical GFAPa expression. GFAPa and GFAPd were
the most abundant isoforms expressed, followed by
GFAPj. Other isoforms were expressed at a very low level
(Sup. Fig. 1f).
First, we confirmed whether GFAPd-induced cyto-
plasmic collapses of GFAP also occurred in the
transduced U251 cells and primary human astrocytes, as
we have shown before in SW13 human adrenal carcinoma
cells and U343 astrocytoma cells [5, 17]. We investigated
the IF network morphology by immunostainings for
GFAP, and we observed that the different GFAP isoforms
gave similar results in both the primary human astrocytes
(Fig. 1a) and the human U251 astrocytoma cells (Fig. 1b).
The endogenous GFAP network was stained in the control
condition, in which cells were transduced with mCherry.
The GFAP network was present throughout the cytoplasm
up to close proximity of the cell periphery, which is
visualized by actin staining. Expression of recombinant
GFAPa in human astrocytes, or in U251 cells, resulted in
a GFAP network which was morphologically similar to
astrocytic IF networks, indicating that the recombinant
GFAPa was incorporated into the endogenous IF network
of the cells. In contrast, expression of GFAPd led to a
collapse of the GFAP network mostly in a perinuclear
fashion (Fig. 1a, b). This perturbing effect of GFAPd on
the GFAP network in these cells is concentration depen-
dent and is a gradual process (data not shown), as has also
been described before [16, 17].
Vimentin and nestin co-collapse with GFAPd,
while actin and microtubules stay intact
To assess whether GFAPd induces a collapse of the com-
plete cytoplasmic IF network, we also studied the
distribution of vimentin (Fig. 2a) and nestin (Fig. 2b),
which were both present in the IF network in primary
human astrocytes. Transduction with GFAPa had no effect
on the intracellular location of these proteins, but trans-
duction with GFAPd led to a condensation of vimentin and
nestin, mostly around the nucleus. The same effect was
observed in the U251 cell line (not shown). The actin and
microtubule cytoskeletal networks did not co-collapse with
the IF network upon GFAPd expression (Fig. 2a, b, Sup.
Fig. 2a, b). The staining intensity of actin was very variable
between cells and between conditions, but the overall
morphology of the actin network showed no actin collapse
induced by GFAPd.
To examine whether the additional expression of
GFAPa or GFAPd would lead to effects on transcription of
other IFs, we analyzed the change in mRNA expression of
vimentin, nestin, and endogenous GFAPa and GFAPd in
U251 cells using quantitative PCR. GFAPa mRNA (Sup.
Fig. 3a), GFAPd mRNA (Sup. Fig. 3b), vimentin mRNA
(Sup. Fig. 3d), and vimentin protein (Sup. Fig. 3e)
levels were not significantly changed due to an increase in
either GFAPa or GFAPd. However, we noticed a small but
significant upregulation of nestin transcript in GFAPa
expressing cells (p = 0.03) (Sup. Fig. 3c).
GFP tagged GFAP incorporates into the endogenous
IF network
Next, we assessed the dynamic properties of GFAP iso-
forms using N-terminally GFP tagged GFAP fusion
proteins for live cell imaging. The transduced cells
express GFP-labeled GFAP isoforms, and thereby, trans-
duced cells can be directly identified based on the reporter
GFP. Both GFP–GFAPa and GFP–GFAPd did incorpo-
rate into the endogenous IF network of U251 cells (Sup.
Fig. 4a, b). Since a high expression of tagged GFAP also
led to a collapse of the network, a relatively low expres-
sion was needed to image a non-collapsed network, which
was established by analysis 24 h after transient transfec-
tion using U251 cells for a reasonable transfection
efficiency. 24 h after transfection, the GFP–GFAPa
transfected cells showed a spread out network (Sup.
Fig. 5a), and GFP–GFAPd expressing cells showed a
mixture of cells with either a spread out network (Sup.
Fig. 5b) or a collapsed IF network (Sup. Fig. 5c). The
endogenous IF network is visualized by the vimentin
staining. About 30 % of the GFP–GFAPd expressing cells
in our cell culture condition showed a collapse at this time
point, although the exact percentage varied between
experiments and was dependent on the transfection
efficiency.
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Fig. 1 GFAP isoform
expression in primary human
astrocytes and U251
astrocytoma cells. a Human
primary astrocytes transduced
with GFAPa, GFAPd, or
mCherry (control). Cells were
stained with pan GFAP Dako
antibody (GFAP) together with
phalloidin (Actin) and Hoechst
(Hst). The reporter showed in
the middle panel which cells
were transduced cells, and these
are additionally highlighted in
the right panel with red stars.
Expression of GFAPa resulted
in a dense GFAP network,
which was spread throughout
the whole cell. Expression of
GFAPd showed a drastic
redistribution of the GFAP
network, which collapsed in a
perinuclear fashion. b Human
U251 astrocytoma cells
transduced with GFAPa,
GFAPd, or mCherry (control)
also showed a collapse of the
GFAP network in GFAPd
transduced cells only. In this
panel, all cells were transduced,
as these were stably transfected
cell lines. A close up of the
collapsed network is shown in
the lowest panel. Scale bars
represent 20 lm
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Live cell imaging of the GFAPd dynamically shows
the collapse of the network
To visualize the dynamics of the collapsing network over
time, U343MG astrocytoma cells transfected with GFP–
GFAPd were imaged for 48 h, starting 4 h after transfec-
tion. U343MG cells were used here, since they are less
motile than U251MG cells, which enabled us to image the
IF network for a long period of time. First, GFP–GFAPd
was distributed throughout the IF network in the whole cell
(arrow in Fig. 3a t = 12 h). GFP–GFAPd started to con-
densate around the nucleus, as the expression of GFP–
GFAPd increased over time (Fig. 3a and Sup. Movies 1
and 2). Sometimes small aggregates or condensations were
seen, which joined the already collapsed GFAP proteins
(arrowheads Fig. 3a t = 30 and Sup. Movies 1 and 2).
Fig. 2 GFAPd collapses the
whole IF network. a Primary
human astrocytes transduced
with GFAPa, GFAPd, or control
plasmid stained for vimentin
and actin or b nestin and actin.
Astrocytes expressing ectopic
GFAPa or mCherry had a
network that was spread
throughout the whole cell while
GFAPd expressing cells showed
a perinuclear collapse of both
vimentin and nestin in cells
positive for the reporter only.
GFAPd transduced cells with
relative low expression, as seen
by lower reporter expression, do
not show a collapsed IF network
yet. Scale bar represents 20 lm
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Fig. 3 Collapse of the IF network due to high GFP–GFAPd
expression. a Stills from a representative live cell imaging experi-
ment. U343MG cells were transfected with GFP–GFAPd and imaged
for 48 h. The GFP–GFAPd was initially incorporated into the IF
network (arrows at t = 12 h), but as the amount of GFP–GFAPd
increased over time, it eventually caused a collapse of the network
(t = 18 h). During the process of collapsing, thicker and shorter
filamentous structures are visible in the cell, which are moving into
the direction of the collapsed network (arrowheads in t = 30 h).
b These small filaments sometimes co-localized with vimentin in
U251MG cells as well (yellow arrow). Scale bars represent 20 lm.
See also supplemental Movie 1 and 2
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During and after the process of the accumulation, cells
were still migrating, and the collapsed IF network was a
motile structure in both stationary and moving cells. These
experiments showed that GFP–GFAPd, in small amounts,
is incorporated into the endogenous IF network before it
causes a collapse of the IF network. Images from fixed cells
stained for GFP, GFAP, and vimentin showed that the
squiggles (short filaments) of GFP–GFAPd sometimes co-
localized with vimentin and were not part of larger fila-
ments (Fig. 3b, arrow).
Dynamic properties of GFP–GFAPa are different
from GFP–GFAPd
To assess the dynamic properties of GFAPa and GFAPd,
FRAP experiments were performed on U251 astrocytoma
cells in which small boxed regions of fluorescent cells were
photobleached, and recovery of fluorescence was measured
over time. Cells were transfected with the GFP–GFAP
isoforms, and the FRAP analysis was started 24 h later.
Cells with non-collapsed and collapsed networks were
measured and analyzed separately. Regions of fluorescent
GFAP networks were bleached, and the fluorescence
recovery was imaged up to 30 min after bleaching. A
typical example is shown in Fig. 4a. The median of all
FRAP recovery experiments for GFAPa and GFAPd in an
extended network and GFAPd in a collapsed network are
shown in Fig. 4d. The half time t (the time needed to
recover to 50 % of the final fluorescence) and the immobile
fraction (the percentage of fluorescence which is not
recovered) were calculated. The median t value of
GFAPd in extended, non-collapsed networks was 2.3 min,
and this was significantly (p\ 0.05) longer than the
median t of GFAPa, which was 1.1 min (Fig. 4b). Since
high GFAPd expression leads to a collapse of the IF net-
work, we next investigated the dynamic properties of
GFAPd in a collapsed network. Although not significant,
there was a clear trend visible that GFAPd had a longer t
(median = 3.8 min) when in a collapsed network com-
pared with GFAPd in a spread out network (Fig. 4b),
indicating a slower on/off rate from the IF network. We
also calculated the immobile fraction of the GFP–GFAPs,
which is the percentage of fluorescence that did not recover
from the FRAP curves. We observed that the immobile
fraction did not significantly differ between GFAPa (me-
dian = 40.3 %) or GFAPd in extended network
(median = 49.1 %). There was, however, a significant
difference between the immobile fraction of GFAPd when
the majority of the GFAP was in a collapsed network
(median = 56.4 %) compared with the immobile fraction
of GFAPa and GFAPd when GFAP was in a spread out
network (Fig. 4c).
To assess whether the change in dynamic properties
between GFAPd when in a network and when it has col-
lapsed was due to the collapse of the network and not
GFAPd itself, we performed experiments in which we also
measured the dynamics of GFAPa in a collapsed network.
To study this, we transfected cells with untagged GFAPd to
induce the collapse, and co-transfected either GFP–GFAPa
or GFP–GFAPd to visualize the fluorescent isoform
dynamics. Both GFP–GFAPa (Sup. Fig. 5a) and GFP–
GFAPd (Sup. Fig. 5b) were incorporated into the collapse
as can be seen by staining for vimentin, which is highly
expressed in U251 cells and shows the endogenous IF
network. A representative example of a bleached collapsed
network and the subsequent recovery is shown in Fig. 5a.
The median t for GFAPa (4.4 min) and GFAPd (5.5 min)
did not differ significantly (p = 0.8) (Fig. 5b). The t
measured for GFAPa was remarkably increased due to the
collapsed network (Fig. 5b). The fluorescence had not yet
reached plateau after 30 min of recovery. Taken together,
this indicates that GFAPa and GFAPd have different
exchange dynamics (as measured by t) and the dynamics
show a trend for higher t when the IF network is
collapsed.
A collapsed IF network changes cell morphology
Next, we aimed at defining whether the IF network collapse
and changes in dynamics also result in a change in mor-
phology, since IF expression has been linked to cell
morphology [40, 43]. Morphological parameters of living
U251 cells expressing different GFAP isoforms were
determined by measuring the cell surface area and the
perimeter. From these parameters, we calculated the form
factor, as described in the methods section. Forty cells were
analyzed per experiment in five independent experiments.
GFAPd expression caused the cells to become rounder
(0.56 ± 0.006; mean ± SEM) in comparison with the
control (0.49 ± 0.005, p = 0.009) (Fig. 6a). We also
observed significant differences in perimeter (Fig. 6b) and
area (Fig. 6c) between cells expressing GFAPd and
GFAPa.
To assess whether the morphological changes we
observed were due to changes in cell-extracellular matrix
interaction, the sizes of focal adhesions were assessed by
phosphorylated paxillin stainings in cells plated on a
laminin substrate. In both GFAPa and GFAPd expressing
cells, the size of the focal adhesion was increased
(mCherry: 1.13 lm2 ± 0.02; GFAPa: 1.34 lm2 ± 0.03;
GFAPd: 1.37 lm2 ± 0.03 (Fig. 6e, f). There was, how-
ever, no transcriptional regulation of the main laminin-
binding integrins expressed in these cells (data not shown).
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GFAP overexpression does not affect cell motility
or cell proliferation
Focal adhesions are tightly regulated during cell migration,
and GFAP has been linked to in vitro migration by others
[4, 43]. To check for changes in cell motility, we analyzed
single cell motility and scratch wound healing speed.
Single cell motility assays were performed on U251 cells
expressing GFAPa, GFAPd, or mCherry. Cells were see-
ded on PLL coated glass coverslips, and thirty cells were
analyzed per experiment in 3 independent experiments.
There were no statistically significant differences in aver-
age velocity between U251 cells expressing GFAPd
(0.53 lm/min ± 0.09), GFAPa (0.44 lm/min ± 0.08), or
control (0.50 lm/min ± 0.02) (p = 0.9) (Fig. 7a). Similar
results were found in a wound healing assay where a
monolayer of cells was scratched and the wound healing
speed was measured over time (Fig. 7g). Wound healing
speed of U251 cells expressing GFAPa (52.9 % ± 9.3),
GFAPd (54.7 % ± 6.2), or the control (50 % ± 7.3) was
not different at 12.5 h (p = 0.7). To study the effects of
GFAP isoform expression on primary cell motility instead
of on tumor cells, single cell motility assays were also done
on primary human astrocytes. Again, we found no statis-
tically significant difference between cell motility of cells
expressing GFAPa (0.39 ± 0.03), GFAPd (0.37 ± 0.02),
and control cells (0.43 ± 0.009) (p = 0.15) (Fig. 7b).
Since GFAPd is highly expressed in proliferating
astrocytes, i.e., neurogenic astrocytes [7, 8] and astrocy-
toma cells [12, 14], we determined the effect of GFAPd
expression on proliferation by performing a 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay [47]. We observed no significant difference
between proliferation of GFAPd (153 % ± 9.2), GFAPa
(180 % ± 19.8), and control (mCherry) (156 % ± 5.3)
(p = 0.56) over a period of 48 h in U251 cells (Fig. 7c).
The MTT assay in primary astrocytes also did not show
significant differences between GFAPa (146 % ± 3.8),
GFAPd (139 % ± 12.5), and control (146 % ± 14.7)
(p = 0.56) (Fig. 7d). To confirm these results, proliferation
was also assessed by staining for the proliferation marker
Phospho histone H3 (PHH3). U251 cells transduced with
the GFAP isoforms were plated, fixed 48 h later, and
stained for PHH3 (Fig. 7e). We observed no significant
difference (p = 0.21) in the percentage of PHH3 positive
cells between GFAPa (7.3 % ± 1.1), GFAPd
(5.4 % ± 0.4), and control (5.6 % ± 0.4). PHH3 staining
in primary astrocytes did, however, show a significant
difference between GFAPa (6.1 % ± 0.3) and GFAPd
(3.4 % ± 0.2) (p = 0.04) (Fig. 7f). Taken together, these
data show that GFAPd expression did not alter cell pro-
liferation or motility, while GFAPa led to a slightly higher
proliferation rate compared with GFAPd.
Discussion
Astrocytes and astrocytoma cells tightly regulate the
expression of at least 10 different GFAP isoforms [6].
GFAPa and GFAPd are the two most highly expressed
isoforms. The functional consequences of changes in the IF
network in astrocytes and astrocytoma cells are still elu-
sive. In this study, we have investigated the effect of
GFAPd on cell proliferation, migration, motility, and shape
but also the intracellular effects on IF network dynamics.
We here show that GFAPa and GFAPd have different
intrinsic dynamic properties, but that expression of GFAPd
does not affect cell proliferation or migration when there is
a collapse of the IF network.
Dynamic properties
GFAPd is assembly compromised by itself [16] and causes
a collapse of the whole IF network. We here show that
even before a collapse, GFAPd changes the dynamics of
the the IF network. Dynamic properties of IF proteins differ
between IF family members [50–53]. These differences are
likely due to phosphorylation or structural properties that
affect the assembly. The latter is for instance reflected in
higher FRAP recovery half time values by the nuclear
lamins (*140 min) [53, 54], which forms IgG-like folds
during assembly [55]. In contrast, GFAP and vimentin,
which are both located in the cytoplasm, have half times
between 1 and 5 min [51, 52]. In this study, we showed that
GFAPd incorporates and dissociates slower from an IF
bFig. 4 Different dynamics between GFAPa and GFAPd. a FRAP
experiments consisted of bleaching ROI and measuring the fluores-
cence recovery up to 30 min after the bleach in U251MG cells.
Within 150 s, most of the fluorescence was recovered, but recovery
was never complete. b FRAP experiments were performed for
GFAPa, GFAPd, and GFAPd in a collapsed network, and half times
were calculated. There is a significant difference in half time between
GFAPa (median = 1.1 min) and GFAPd (median = 2.3 min)
(p\ 0.05; n = 33, n = 30), and between GFAPa and GFAPd in a
collapsed network (median = 3.8 min) (p = 0.000; n = 32). There
was no significant difference in the half time of GFAPd in spread out
or collapsed network, although there was a trend that a collapse
decreased the half time of GFAPd. c The immobile fractions were not
significantly different between GFAPa (40.2 %), GFAPd (49.1 %)
(p = 0.7; n = 29 and n = 30). GFAPd in a collapse did have a
significantly different immobile fraction (56.3 %; n = 32) compared
with GFAPa (p = 0.03) and GFAPd (p = 0.04) in a network. Graphs
b and c show median values with interquartile range. d Medians of
FRAP curves for GFAPa, GFAPd and GFAPd in a collapse show the
recovery after bleaching. Non-parametric tests were performed on the
data extracted from the FRAP measurements, so non-overlapping
curves do not equal significant differences in this graph
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network than GFAPa. Since the C-terminal tail is the only
difference between GFAPa and GFAPd, the differences in
dynamics must be due to this specific sequence. IF protein
motility and exchange are mediated through interactions
with microtubules and actin to regulate transport [50], and
IF protein phosphorylation to regulate filament stability
[25, 56, 57]. In the part of the C-terminus, where GFAPa
and GFAPd differ, the same amount of putative phospho-
rylation sites are present (7 residues). However, the
position of these residues is different, possibly leading to a
different availability of phosphorylatable residues in the
protein tertiary structure. In the tail of GFAPd is a coil 2B
Fig. 5 Dynamics of GFAP isoforms in a collapsed IF network. a A
representative still of a FRAP experiment on U251MG cells with a
collapsed IF network. ROIs were bleached and the fluorescence
recovery was measured for up to 35 min. Even after 30 min, the
bleach area was still clearly visible. b Half times were calculated as
described in the materials and methods section. There were no
significant differences between the half time of GFAPa in a collapse
(median = 4.5 min) or GFAPd in a collapse (median = 5.5 min)
(p = 0.8; n = 8). There was a clear trend showing that a collapse
caused a longer half time (4.5 vs. 1.1 min for GFAPa and 5.5 vs.
2.3 min for GFAPd) of the GFAP isoforms
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binding site, which lacks in the GFAPa tail [16]. It has
been proposed by Nielsen and Jorgensen [16] that this
domain results in a gain of coiled-coil binding activity of
GFAPd, which might explain the slower dissociation of
GFAPd from an IF network. Earlier experiments have
shown that ablation of the whole C-terminal tail of IF type
III proteins inhibits IF assembly [38, 58], but phosphory-
lation of vimentin at the C-terminal side did not affect its
assembly [59]. Mutant GFAP isoforms, with mutated
phosphorylation sites, will help to elucidate the effects of
GFAP phosphorylation on network dynamics.
Effect on proliferation, motility, and migration
In this study, we showed that a GFAPd-induced collapse of
the IF network results in a reorganization of the whole IF
network. This is in contrast with a knockout or knockdown
of GFAP, which does not severely affect vimentin or nestin
localization [40]. GFAP, as well as other IFs, has been
linked to changes in proliferation and astrocyte motility,
but it has to be noted that the studies on the role of GFAP
in cell proliferation are inconclusive. A GFAP knockdown
has been shown to lead to an increase in proliferation in
some studies [4, 60], but not in others [61]. On the other
hand, astrocyte cultures of transgenic mice overexpressing
human GFAPa showed a decrease in proliferation [62].
Since GFAPd is expressed in cycling cells in the human
brain [8, 12, 14], we expected an effect of GFAPd on cell
proliferation. Unexpectedly, we observed that not the
expression of GFAPd, but an enhanced expression of
GFAPa resulted in a significant increase in proliferation of
primary astrocytes. We detected a similar trend in the U251
astrocytoma cells. Our data show that the increase in pro-
liferation is caused by the mere increase in GFAPa and that
there is no direct role of GFAPd in cell proliferation in cells
with a collapsed IF network. Lowering the ratio of GFA-
Pa:GFAPd making sure that there is still an intact network
also did not change cell proliferation in vitro [40].
Several studies have found that a knockdown or
knockout of GFAP increases cell motility [4, 43, 63]. In
addition, we recently showed that a specific knockdown of
GFAPa leads to a reduced motility in astrocytoma cells
[40].Here, we show that an overexpression of GFAPa or
GFAPd has no effect on cell motility, even if the IF net-
work is collapsed by high GFAPd levels. Regulation of
motility by GFAP is rather complex. Mutations in the rod
domain of GFAP that causes collapses of the network, and
thus mimics our GFAPd condition, have been shown to
increase cell motility. In contrast, mutations in the tail
domain of GFAP had no effect on motility [64, 65].
GFAPa and GFAPd only differ in the C-terminal tail, thus
this might explain why we do not see differences in cell
motility.
Effect on ECM interaction
GFAP has been linked to cell morphological changes in
astrocytes in vitro, where a correlation was observed
between the level of GFAP expression and the number of
cell protrusions [4, 41–43, 61]. In reactive gliosis, the
production of GFAP as well as other IF proteins is
upregulated. This results in a more pronounced, GFAP-
positive, IF network [66–68]. Here, we show that the col-
lapse of the IF network due to GFAPd expression resulted
in more round cells with longer focal adhesions in vitro.
This change resembles the morphological change in
astrocytes devoid of IFs in vitro [4, 41, 43, 61]. Thus, an
intact IF network is important for the formation or stabi-
lization of processes of cells. In our earlier study, we
showed, however, that a pan-GFAP knockdown in U373
cells did not result in a rounder morphology [40]. This is
probably due to the presence of an intact vimentin and
nestin IF network, which is lacking in the cells with a
GFAPd-induced collapse.
The change we observed in cell morphology in cells
with a GFAPd-induced collapsed IF network shows that the
IF network distribution per se can affect the shape of the
cell. The way GFAPd alters shape is likely to occur through
integrins. Integrins are the main linkers between the
extracellular matrix and the cytoskeleton in vivo and,
together with other proteins, they form the focal adhesions.
Focal adhesions can be present in different sizes and
maturation states, ranging from small structures, of less
than 1 lm, to larger focal adhesions. Focal adhesion size is
dependent on actomyosin generated tension [69, 70].
Indeed, interactions between the IF protein vimentin and
mature focal adhesions have been shown to be essential for
proper cell spreading [71]. Vimentin can regulate adhesion
and focal contact size under shear stress [72] and controls
cell adhesion strength through plectin and b3 integrins
[73]. Thus, GFAP could have a similar function in adhe-
sion of astrocytes to the ECM and in this way alter cell
shape. Our data confirm a direct effect of the IF constel-
lation on focal adhesions and cell–matrix interactions, as
both GFAP isoforms increase focal adhesion size. Since
only GFAPd expressing cells showed altered morphology,
this implies a difference in the effect GFAPa and GFAPd
has on the functionality of focal adhesions. This might
partly be due to differences in production of ECM mole-
cules, such as laminin, as we have shown before [40].
Although the exact interaction of GFAP with focal adhe-
sions is still elusive, interactions between other IFs and
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focal adhesions have been described, as is nicely reviewed
by Leube et al. [74].
Conclusion
To summarize, we have shown that a GFAPd-induced
collapse of the IF network has a profound effect on IF
network morphology, increases focal adhesion size, and
changes the IF network dynamics, without altering astro-
cyte motility or proliferation. Although GFAPd is
expressed in more proliferative cell types with a higher
migration potential, GFAPd itself does not directly
Fig. 7 Migration and proliferation is not affected by GFAPd. a Single
cell motility was measured as the average velocity in lm/min of a
single cell, in a sequence of images, which were taken overnight.
Average velocity did not differ significantly between GFAPa,
GFAPd, and control cells (p = 0.9) (n = 3) in U251 cells or in
b primary astrocytes (p = 0.15) (n = 3). c Proliferation was
measured by metabolic conversion of MTT, which was measured
by absorbance of light. The absorbance at t = 24 h was put at 100 %.
There was no significant difference between GFAPd, GFAPa, and
control (p = 0.56) (n = 3) at 48 h in U251 cells or d primary
astrocytes (p = 0.56) (n = 3). e Cells were stained for PHH3,
indicating dividing cells. The average percentage of dividing cells per
condition at one time point is not significantly different in cells with
GFAPa, GFAPd, and control in U251 cells (p = 0.21) (n = 4) (f). In
primary astrocytes, there was a significant difference in proliferation
between GFAPa and GFAPd (p = 0.04) (n = 3). g Scratch assays
were done by scratching a monolayer of cells and measuring the area
uncovered by cells, over time. The area of the scratch at t = 0 was put
at 100 %. The bars represent the area where there are no cells at
different time points. There was no significant difference (p = 0.7)
(n = 3) between GFAPa, GFAPd, and the control after 12.5 h. All
graphs show mean with SEM
Fig. 6 Morphology of U251 cells with different IF networks.
a GFAPd expressing cells showed a more round morphology in
comparison to the control (p = 0.009) as is measured by the form
factor of these cells. Significant differences between GFAPa and
GFAPd were found in b perimeter (p = 0.02) and c area (p = 0.03).
Bars show mean and SEM (n = 5). d Phase contrast pictures showing
the more round morphology of the GFAPd expressing cells in
comparison with the control vector and GFAPa. Scale bars represent
100 lm. e U251 cells expressing different GFAP isoforms are stained
for actin with phalloidin (green) and phosphorylated paxillin (red).
Scale bars represent 10 lm. The lower panel shows focal adhesions
(overlap of phalloidin and phosphorylated paxillin). f Quantification of
focal adhesion shows larger focal adhesion size in GFAPa
(p = 0.0001) and GFAPd (p = 0.001) expressing cells compared with
the control mCherry (mCherry: 1.13 lm2 ± 0.02 n = 735; GFAPa:
1.34 lm2 ± 0.03 n = 994; GFAPd: 1.37 lm2 ± 0.03 n = 828
b
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influence proliferation or migration when there is a col-
lapse of the IF network. The changes in IF network
dynamics could hold clues to GFAP isoform specific
functions.
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